11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
1 min read
Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit
The Evolution Summit is an invitation-only, premium summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
Veristat thought-leader Shaheen Limbada, EVP Innovation and Strategy will be meeting with leading clinical trial executives and innovative suppliers and solution providers during this event.
Be sure to schedule your meeting while there is time.
DATE: 24 May - 26 May 2023
LOCATION: Encore Boston Harbor | Boston, MA
Shaheen Limbada
Executive Vice President, Innovation and Strategy, Veristat
Shaheen Limbada is the Executive Vice President of Innovation and Strategy of Veristat. In this role, Shaheen oversees identifying and building strategic, innovative solutions to advance the clinical development goals of our clients. With over 22 years of experience running clinical trials, he excels in innovative clinical trial solutions, clinical trial execution, business strategy and business growth. He will initially be focused on applying his skills to enhance and build Veristat's pharmacovigilance, commercialization, and decentralized clinical trial solutions.
Shaheen spent four years as the Executive Vice President of Global Clinical Operations at Veristat, where he fully integrated new processes for adopting digital and virtual components to improve the patient experience of participating in clinical trials. He joined Veristat through the acquisition of Topstone Research, a Canadian-based CRO he co-founded, and held the position of Managing Director. Before Topstone, he worked in clinical operations, project management, and leadership roles at various clinical research organizations (CROs) and pharmaceutical firms, including Leo Pharma, Cetero Research, and AstraZeneca.
Mr. Limbada graduated from the University of Toronto and quickly began his career in clinical trials with AstraZeneca Canada Inc.
Learn More
- Download our Decentralized Trials Infographic
- Learn more about our Regulatory Consulting Expertise
- Download our IND Infographic